January 13, 2021
SymBio Pharmaceutical rolled out on January 12 a ready-to-dilute (RTD) liquid formulation of its anticancer agent Treakisym Injection Solution (bendamustine) in Japan, it said on the same day. In comparison with its existing lyophilized formulation, the RTD version will enable...read more